by ChampionTeam | Oct 13, 2025 | Peptides
Key Research Findings 2025 multicenter trial of 1,106 sepsis patients showed 28-day mortality reduction with thymosin alpha 1 treatment Mechanism targets CD4+ T cell enhancement and CD4+/CD8+ ratio optimization for superior immune function Clinical evidence...
by ChampionTeam | Oct 13, 2025 | Peptides
Key Research Findings Recent 2025 studies show Thymosin Beta-4 promotes neuroprotection through BDNF upregulation and TrkB receptor enhancement TB500 mechanisms involve direct ROCK1 protein modulation and SLC7A11 pathway regulation for cellular protection Clinical...
by ChampionTeam | Oct 13, 2025 | Peptides
Key Research Findings Clinical trials demonstrate 25% reduction in visceral adipose tissue with tesamorelin treatment over 26 weeks Growth hormone-releasing hormone analog shows neuroprotective effects in HIV-associated cognitive impairment studies Tesamorelin...
by ChampionTeam | Oct 13, 2025 | Peptides
Key Research Findings SS-31 demonstrates 35% improvement in ATP production and 40% reduction in ROS levels in aged bone marrow stem cells Phospholipid scramblase 3 (PLSCR3) identified as essential mediator of SS-31’s mitochondrial protective effects Clinical...
by ChampionTeam | Oct 6, 2025 | Peptides
SLU-PP-332 demonstrates significant metabolic improvements with 25 lb fat mass reduction in diet-induced obesity models Functions as pan-ERR agonist with highest potency for ERRα activation and exercise mimetic properties Clinical research shows improved ejection...
Reconstitution Kit
$15.00
GLP3 15mg
$125.00
GLP3 30mg
$210.00
Cagrilintide 10mg
$89.00
Mazdutide 10mg
$84.00